Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation.

O'Neal WT, Sandesara PB, Claxton JS, MacLehose RF, Chen LY, Bengtson LGS, Chamberlain AM, Norby FL, Lutsey PL, Alonso A.

Am J Cardiol. 2018 Aug 1;122(3):388-394. doi: 10.1016/j.amjcard.2018.04.022. Epub 2018 May 1.

2.

Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.

O'Neal WT, Claxton JS, Sandesara PB, MacLehose RF, Chen LY, Bengtson LGS, Chamberlain AM, Norby FL, Lutsey PL, Alonso A.

J Am Coll Cardiol. 2018 Oct 16;72(16):1913-1922. doi: 10.1016/j.jacc.2018.07.077.

3.

Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.

O'Neal WT, Sandesara PB, Claxton JS, MacLehose RF, Chen LY, Bengtson LGS, Chamberlain AM, Norby FL, Lutsey PL, Alonso A.

J Am Heart Assoc. 2018 Mar 10;7(6). pii: e007943. doi: 10.1161/JAHA.117.007943.

4.

Factors driving anticoagulant selection in patients with atrial fibrillation in the United States.

Lauffenburger JC, Farley JF, Gehi AK, Rhoney DH, Brookhart MA, Fang G.

Am J Cardiol. 2015 Apr 15;115(8):1095-101. doi: 10.1016/j.amjcard.2015.01.539. Epub 2015 Feb 2.

5.

Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.

Yu AYX, Malo S, Svenson LW, Wilton SB, Hill MD.

J Am Heart Assoc. 2017 Oct 28;6(11). pii: e007129. doi: 10.1161/JAHA.117.007129.

7.

Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.

Lip GY, Laroche C, Popescu MI, Rasmussen LH, Vitali-Serdoz L, Dan GA, Kalarus Z, Crijns HJ, Oliveira MM, Tavazzi L, Maggioni AP, Boriani G.

Europace. 2015 Dec;17(12):1777-86. doi: 10.1093/europace/euv269. Epub 2015 Aug 30.

PMID:
26321406
8.

Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.

Essien UR, Holmes DN, Jackson LR 2nd, Fonarow GC, Mahaffey KW, Reiffel JA, Steinberg BA, Allen LA, Chan PS, Freeman JV, Blanco RG, Pieper KS, Piccini JP, Peterson ED, Singer DE.

JAMA Cardiol. 2018 Dec 1;3(12):1174-1182. doi: 10.1001/jamacardio.2018.3945.

PMID:
30484833
9.

Substantial differences in initiation of oral anticoagulant therapy and clinical outcome among non-valvular atrial fibrillation patients treated in inpatient and outpatient settings.

Mikkelsen AP, Hansen ML, Olesen JB, Hvidtfeldt MW, Karasoy D, Husted S, Johnsen SP, Brandes A, Gislason G, Torp-Pedersen C, Lamberts M.

Europace. 2016 Apr;18(4):492-500. doi: 10.1093/europace/euv242. Epub 2015 Oct 5.

PMID:
26443443
10.

Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk.

Lubitz SA, Khurshid S, Weng LC, Doros G, Keach JW, Gao Q, Gehi AK, Hsu JC, Reynolds MR, Turakhia MP, Maddox TM.

Am Heart J. 2018 Jun;200:24-31. doi: 10.1016/j.ahj.2018.03.003. Epub 2018 Mar 10.

11.

Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.

Palamaner Subash Shantha G, Bhave PD, Girotra S, Hodgson-Zingman D, Mazur A, Giudici M, Chrischilles E, Vaughan Sarrazin MS.

Circ Cardiovasc Qual Outcomes. 2017 Apr;10(4). pii: e003418. doi: 10.1161/CIRCOUTCOMES.116.003418.

12.
13.

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.

Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Mochizuki H, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Kario K, Sato S, Koga M; SAMURAI Study Investigators.

Int J Stroke. 2015 Aug;10(6):836-42. doi: 10.1111/ijs.12452. Epub 2015 Jan 12.

14.

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.

AbuDagga A, Stephenson JJ, Fu AC, Kwong WJ, Tan H, Weintraub WS.

BMC Health Serv Res. 2014 Jul 17;14:310. doi: 10.1186/1472-6963-14-310.

15.

Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: cross-sectional population database study.

Dreischulte T, Barnett K, Madhok V, Guthrie B.

Eur J Gen Pract. 2014 Sep;20(3):181-9. doi: 10.3109/13814788.2013.852535. Epub 2013 Dec 19.

PMID:
24351017
16.

Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.

Baturova MA, Lindgren A, Carlson J, Shubik YV, Bertil Olsson S, Platonov PG.

Int J Cardiol. 2017 Apr 1;232:134-139. doi: 10.1016/j.ijcard.2017.01.040. Epub 2017 Jan 5.

PMID:
28132778
17.

Changes in Oral Anticoagulant Treatment Rates in Atrial Fibrillation before and after the Introduction of Direct Oral Anticoagulants.

Shah RU, Rupp AB, Mowery D, Zhang M, Stoddard G, Deshmukh V, Bray BE, Hess R, Rondina MT.

Neuroepidemiology. 2016;47(3-4):201-209. doi: 10.1159/000455012. Epub 2017 Jan 31.

PMID:
28135707
18.

The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.

Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ.

J Manag Care Pharm. 2013 May;19(4):302-16.

19.

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O'Brien EC, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.

Am Heart J. 2017 Jul;189:40-47. doi: 10.1016/j.ahj.2017.03.024. Epub 2017 Apr 4.

20.

Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.

Hsu JC, Maddox TM, Kennedy K, Katz DF, Marzec LN, Lubitz SA, Gehi AK, Turakhia MP, Marcus GM.

J Am Coll Cardiol. 2016 Jun 28;67(25):2913-23. doi: 10.1016/j.jacc.2016.03.581.

Supplemental Content

Support Center